Press release -

QleanAir and BioLamina signs groundbreaking cleanroom contract

QleanAir Holding AB (publ), the premium provider of solutions for clean indoor air, have signed a contract for a new cleanroom with BioLamina, a Swedish biotechnological company. The order is the company’s largest to date with a total value of 12,4 MSEK.

Stockholm-based biotechnology company, BioLamina develops products for cell culture based on genetically engineered proteins, so-called laminins (Biolaminin(R). BioLamina has selected QleanAir to develop and build a 340 m² large GMP-classed cleanroom for production and research within process development, matrix biology and cellular assays.

– We have chosen QleanAir because they could both project manage and deliver a solution tailored to our needs at high demands within a short time frame, says Anders Lindblad, Interim CEO of BioLamina. With this new facility, we will be able to four-fold our overall manufacturing capacity and better serve our customers within the fields of research and cell therapy. Production is scheduled to start in January 2022.

The order is QleanAir largest to date, both within the product category Room solutions and in total, since the company was founded. The order is a product sale of 12.4 MSEK that will be included in the order intake in the third quarter. In addition to the clean room order, there will be a separate service agreement. QleanAir’s cleanroom team will start working with situation analysis and solution design immediately, in close collaboration with representatives from BioLamina.

– We are very pleased to be a part of the very important scientific work being done by BioLamina. This order is a very strong validation of our offering within cleanrooms and our track record of delivering clean room solutions to leading organizations within life science and biotechnology, says Christina Lindstedt, CEO of QleanAir.

BioLamina AB is a Swedish biotechnology company built on a scientific foundation with a legacy in matrix biology and cell culture-based research. Their flagship products, their biorelevant human recombinant laminin isoforms, Biolaminin®, are defined cell culture matrices that successfully imitate the natural, cell-specific cell-matrix interaction in the cell culture dish, allowing the cells to thrive and maintain their function. Their products are a powerful resource for scientists working with stem cells and primary cells both within basic research as well as in regenerative medicine companies with focus on cell therapy applications.

Related links

Topics

  • Medical research

Categories

  • aseptic space
  • stem cell research
  • biotechlology
  • controlled environment
  • air cleaning
  • air quality
  • biotech
  • laminins
  • cell culture matrice
  • matrix biology

QleanAir is the premium supplier of solutions for clean and controlled indoor air for professional purposes. Our solutions are based on mechanical filtration with a constant air flow which in combination with preventive service ensures functionality and air quality over time. The product portfolio consists of turnkey cleanrooms, freestanding air cleaners for production facilities, offices, healthcare schools, public spaces warehousing and logistics, and solutions for protection against passive smoking. QleanAir's solutions are available in 30 countries, are delivered as a service and all have a Lifetime Performance Guarantee.

Contacts

Related content

  • Colly Flowtech’s new cleanroom creates new business opportunities

    Colly Flowtech’s new business area Ultrapure has seen a huge demand for compact single-use products from customers in LifeScience, pharma and Biotech. Their new cleanroom from QleanAir has given the company a whole new flexibility, speed, and the opportunity to build prototypes.

  • Take a 3D Walk-through Tour of our Cleanrooms

    For more than 30 years, we have developed innovative solutions to protect people, products, and processes. Our modular cleanrooms are designed for extra-sensitive environments with stringent requirements of cleanliness that can be tailored to every client's needs. Curious to see how they work? Take a 3D walk-through of our cleanrooms.

  • Der neue Reinraum von Colly Flowtech schafft neue Geschäftsmöglichkeiten

    Der neue Geschäftsbereich Ultrapure von Colly Flowtech erlebt eine enorme Nachfrage nach kompakten Einwegprodukten von Kunden aus den Bereichen LifeScience, Pharma und Biotech. Der neue Reinraum von QleanAir bietet Unternehmen beispiellose Flexibilität und Geschwindigkeit sowie die Möglichkeit, Prototypen zu bauen.

  • La nouvelle salle blanche de Colly Flowtech crée de nouvelles opportunités commerciales

    Le nouveau secteur d’activité Ultrapure de Colly Flowtech a constaté une énorme demande de produits compacts à usage unique de la part des clients des secteurs des sciences de la vie, de la pharmacie et des biotechnologies. Sa nouvelle salle blanche de QleanAir a donné à l’entreprise une toute nouvelle flexibilité, une nouvelle vitesse et la possibilité de construire des prototypes.

  • Absolute Pharmacy upgrades to a cleanroom from QleanAir

    Absolute Pharmacy provides drugs for patients treated at home or in long-term care facilities. With their new cleanroom from QleanAir, they make sure that the compounding is done in an efficient and safe way. Protecting the safety for patients and employees, while making sure the long-term care facilities have the right drugs, at the right time and the right price.

  • Absolute Pharmacy s’équipe d’une salle blanche de QleanAir

    Avec leur nouvelle salle blanche de QleanAir, Absolute Pharmacy s'assure que la préparation est effectuée de manière efficace et sûre. Protégant la sécurité des patients et des employés, tout en veillant à ce que les établissements de soins de longue durée disposent des bons médicaments, au bon moment et au bon prix.